These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1952873)

  • 41. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
    Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
    Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
    Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA
    J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Properties of cephalosporinase from Proteus morganii.
    Toda M; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phospholipid bilayer permeability of beta-lactam antibiotics.
    Yamaguchi A; Hiruma R; Sawai T
    J Antibiot (Tokyo); 1982 Dec; 35(12):1692-9. PubMed ID: 6762375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance categories of enterobacteria to beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Infect Dis; 1975 Sep; 132(3):233-40. PubMed ID: 1041500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of beta-lactam antibiotics by Legionella pneumophila.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):561-4. PubMed ID: 316686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sec- and Tat-dependent translocation of beta-lactamases across the Escherichia coli inner membrane.
    Pradel N; Delmas J; Wu LF; Santini CL; Bonnet R
    Antimicrob Agents Chemother; 2009 Jan; 53(1):242-8. PubMed ID: 18981261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    Siebert WT; Moreland N; Williams TW
    J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
    Flores AR; Parsons LM; Pavelka MS
    Microbiology (Reading); 2005 Feb; 151(Pt 2):521-532. PubMed ID: 15699201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs.
    Petersen SW; Rosin E
    Vet Surg; 1995; 24(4):347-51. PubMed ID: 7571387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Medeiros AA; Kent RL; O'Brien TF
    Antimicrob Agents Chemother; 1974 Dec; 6(6):791-801. PubMed ID: 4615632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between beta-lactamase activity and resistance to beta-lactam antibiotics in Mycobacterium smegmatis.
    Yabu K; Kaneda S; Ochiai T
    Microbiol Immunol; 1985; 29(9):803-9. PubMed ID: 3877858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
    Wu PJ; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
    Malouin F; Lamothe F
    Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catalytic properties of an endogenous beta-lactamase responsible for the resistance of Azospirillum lipoferum to beta-lactam antibiotics.
    Boggio SB; Roveri OA
    Microbiology (Reading); 2003 Feb; 149(Pt 2):445-450. PubMed ID: 12624206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins.
    Acar JF; Sabath LD; Ruch PA
    J Clin Invest; 1975 Mar; 55(3):446-53. PubMed ID: 163847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative study of 7 cephalosporins on "Staphylococcus aureus" by the method of population analysis (author's transl)].
    Sirot D; Sirot J; Cluzel R; Joly B
    Pathol Biol (Paris); 1977 Nov; 25(9):605-10. PubMed ID: 341049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.